Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

Hepatology

Volumn 27, Issue 1, 1998, Pages 254-263

  Protzer Knolle, U ^a   Naumann, U ^a   Bartenschlager, R ^a   Berg, T ^a   Hopf, U ^a   Zum Buschenfelde, K H M ^a   Neuhaus, P ^a   Gerken, G ^a   Locarnini, S A ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0031983151     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270138     Document Type: Article

References (44)

1. 1 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus‐related liver disease [Comments]. Hepatology 1991 ; 13: 619–626. MEDLINE
2. 2 Perillo R, Mason A. Hepatitis B and liver transplantation. Problems and promises [Editorial]. N Engl J Med 1993 ; 329: 1885–1887. MEDLINE
3. 3 Laskus T, Rakela J, Steers JL, Wiesner RH, Persing DH. Precore and contiguous regions of hepatitis B virus in liver transplantation for end‐stage hepatitis B. Gastroenterology 1994 ; 107: 1774–1780. MEDLINE
4. 4 Calmus Y, Hannoun L, Dousset B. HLA class I matching is responsible for the hepatitic lesions in recurrent viral hepatitis B after liver transplantation. Transplant Proc 1990 ; 22: 2311–2313. MEDLINE
5. 5 Lau JY, Bain VG, Smith HM, Alexander GJ, Williams R. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 1992 ; 53: 894–898. MEDLINE
6. 6 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985 ; 317: 489–495. MEDLINE
7. 7 Bismuth H. Consensus statement on indications for liver transplantation: Paris, June 22–23, 1993. Hepatology 1994 ; 20 (Suppl: 63S–68S. MEDLINE
8. 8 O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992 ; 14: 104–111. MEDLINE
9. 9 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J, Bismuth H. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 1993 ; 329: 1842–1847. MEDLINE
10. 10 König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, Bechstein W‐O, et al. Long‐term follow‐up of Hepatitis B Virus infected recipients after orthotopic liver transplantation. Transplantation 1994 ; 58: 1–7. MEDLINE
11. 11 Carman W, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, et al. Vaccine‐induced escape mutant of hepatitis B virus. Lancet 1990 ; 336: 325–329. MEDLINE
12. 12 Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. Loss of the common “A” determinant of hepatitis B surface antigen by a vaccine‐induced escape mutant. J Clin Invest 1992 ; 90: 2543–2547. MEDLINE
13. 13 Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994 ; 75: 443–448. MEDLINE
14. 14 Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, et al. Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992 ; 184: 1152–1157. MEDLINE
15. 15 Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995 ; 13: 699–702. MEDLINE
16. 16 Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine‐induced escape mutant of hepatitis B virus. J Hepatol 1991 ; 13 (Suppl 4: S105–S107. MEDLINE
17. 17 Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992 ; 32: 264–268. MEDLINE
18. 18 McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody‐treated liver transplant patients. Hepatology 1992 ; 15: 757–766. MEDLINE
19. 19 Hawkins A, Gilson RJ, Gilbert N, Wreghitt TG, Gray J, Ahlers‐de‐Boer I, Tedder RS, et al. Hepatitis B surface mutations associated with infection after liver transplantation. J Hepatol 1996 ; 24: 8–14. MEDLINE
20. 20 Carman WF, Trautwein C, van Deursen F, Colman K, Dornan E, McIntyre G, Waters J, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996 ; 23: 489–493.
21. 21 Cariani E, Ravaggi A, Tanzi E, Romano L, Fiordalisi G, Bellati G, Caccamo L, et al. Emergence of hepatitis B virus S gene mutant in a liver transplant recipient. J Med Virol 1995 ; 47: 410–415. MEDLINE
22. 22 Pride MW, Thanavala YM, Strick N, Houghten RA, Neurath AR. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122–136). Pept Res 1992 ; 5: 217–226. MEDLINE
23. 23 Motti C, Nuzzo M, Meola A, Galfre G, Felici F, Cortese R, Nicosia A, et al. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 1994 ; 146: 191–198. MEDLINE
24. 24 Chen Y‐C, Delbrook K, Dealwis C, Mimms L, Mushawar I, Mandecki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. PNAS 1996 ; 93: 1997–2001. MEDLINE
25. 25 Berting A, Hahnen J, Kröger M, Gerlich W. Computer‐aided studies on the spacial structure of the small hepatitis B surface protein. Intervirology 1995 ; 38: 8–15. MEDLINE
26. 26 Knodell RG, Tshak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 ; 1: 431–435. MEDLINE
27. 27 Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, et al. Comparison of FK506‐ and cyclosporine‐based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 1995 ; 59: 31–40. MEDLINE
28. 28 Naumann U, Protzer‐Knolle U, Berg T, Leder K, Lobek H, Bechstein WO, Gerken G, et al. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti‐hepatitis B virus surface antigen immunoprophylaxis. Hepatology 1997 ; 26: 478–484. MEDLINE
29. 29 Protzer U, Goergen B, Hopf U, Neuhaus P, König V, Meyer zum Büschenfelde K‐H, Gerken G. Pre‐core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation. J Med Virol 1996 ; 50: 135–144. MEDLINE
30. 30 Norder H, Courouce AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992 ; 73: 3141–3145. MEDLINE
31. 31 Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993 ; 74: 1341–1348. MEDLINE
32. 32 Eble BE, Lingappa VR, Ganem D. Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol Cell Biol 1986 ; 6: 1454–1463. MEDLINE
33. 33 Mimms L, Goetze A, Swanson S, Floreani M, Edwards B, Macioszek J, Okasinski G, et al. Second generation assays for the detection of antibody to HBsAg using recombinant DNA‐derived HBsAg. J Virol Methods 1989 ; 25: 211–231. MEDLINE
34. 34 Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S‐gene. Intervirology 1995 ; 38: 24–34. MEDLINE
35. 35 Wallace LA, Echevarria JE, Echevarria JM, Carman WF. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 1994 ; 170: 1300–1303. MEDLINE
36. 36 Bruce SA, Murray K. Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. J Med Virol 1995 ; 46: 157–161. MEDLINE
37. 37 Steward MW, Partidos CD, D'Mello F, Howard CR. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 1993 ; 11: 1405–1414. MEDLINE
38. 38 Bhatnagar PK, Papas E, Blum HE, Milich DR, Nitecki D, Karels MJ, Vyas GN. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A 1982 ; 79: 4400–4404. MEDLINE
39. 39 Neurath AR, Pride MW, Strick N, Thanavala YM. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139–147). Pept Res 1990 ; 3: 116–122. MEDLINE
40. 40 Chirara MM, Chetsanga CJ. Variant of hepatitis B virus isolated in Zimbabwe. J Med Virol 1994 ; 42: 73–78. MEDLINE
41. 41 Jiang JJ, Brind A, Gigou M, Samuel D, Feray C, Brechot C, Kremsdorf D. Evidence for the role of PBMC in the infection of liver graft and selection of hepatitis B variants after liver transplantation [Abstract]. J Hepatol 1994 ; 21 (Suppl: S21.
42. 42 Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo R, Imai M, Miyakawa Y, Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988 ; 69: 2575–2583. MEDLINE
43. 43 Lauder IJ, Lin HJ, Lau JY, Siu TS, Lai CL. The variability of the hepatitis B virus genome: statistical analysis and biological implications. Mol Biol Evol 1993 ; 10: 457–470. MEDLINE
44. 44 Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 1990 ; 64: 613–620. MEDLINE